• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

EXPRESSION OF RECOMBINANT PLATELET GLYCOPROTEIN IB/IX AND EFFECT OF POST-TRANSLATIONAL MODIFICATION ON ITS FUNCTIONS

Research Project

Project/Area Number 05670930
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Hematology
Research InstitutionKEIO UNIVERSITY

Principal Investigator

MURATA Mitsuru  SCHOOL OF MEDICINE,KEIO UNIVERSITY Assistant, 医学部, 助手 (50174305)

Project Period (FY) 1993 – 1995
KeywordsPLATELETS / VON WILLEBRAND FACTOR / THROMBOSIS / MEMBRANE GLYCOPROTEINS / MUTANTS / PROTEIN TYROSINE SULFATION / POST-TRANSLATIONAL MODIFICATION / BLEEDING DIATHESIS
Research Abstract

The interaction of von Willebrand factor (vWF) and its one of the platelet receptorsglycoprotein (GP) Ib/IX complex, triggers platelet aggregation and plays a key role in regulating the initial step of platelet thrombus formation. In order tocharacterize the mechanisms that regualate the interaction, we have expressed a recombinant GP Ib/IX protein in mammalian cells and investigated the effect of amino acid substitutions or the changes in post-translational modifications on the receptor function. (1) We have analyzed the genomic DNA of patients with platelet-type von Willebrand disease, which is characterized by an abberant GPIb/IX with abnormally high affinity for vWF,and have found a point mutation in the alpha chain of the receptor. Furthemory, we have expressed in CHO cells the mutant pretein, which possessed the phenotypic abnormality of the disorder, the enhenced interaction with the ligand. (2) Substitutiuon of potentially sulfated three tyrosine residues with phenylalanine residues resulted in the loss of vWF binding function of the rteceptor. Recombinant protein expressed in CHO cells cultured in a condition that blocks protein tyrosine sulfation, i. e., in the presence of sodium chrolate, had impaired vWF binding function. (3) We have also improved the cell culture technique to obtain large amount of the recombinant protein, since this soluble recombinant protein inhibits the normal vWF binding to platelets thus having the potential role in the prevention of platelet thrombus formation. Our results provides essential informations for the basic mechanisms of arterial thrombosis and for the development of newantiplatelet therapies.

  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Takahashi H,Murata M et al: "Substitution of Val for Met at vesidue 239 of platelet glycoprotein Ibd in Japanese patients with platelet-type von Willebrand disease" Blood. 85. 727-733 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Marchese P, Murata M et al: "Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding" J. Biol. Chem.270. 9571-9578 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakagawa-Nishimura Y et al: "Shear stress-induced platelet aggregation in various types of von Willebrand disease." Int.J.Hematol. 61. 189-196 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Marchese P et al: "Indentification of three tyrosine residues of glycoprotein Ibalpha with distinct roles in von Willebrand factor and alpha-thrombin binding." J.Biol.Chem. 270 (16). 9571-9578 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi H et al: "Substitution of Val for Met at residue 239 of platelet glycoprotein Ibalpha in Japanese patients with platelet-type von Willebrand disease." Blood. 85 (3). 727-733 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murata M et al: "Low shear stress can initiate von Willebrand factordependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease."

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] J.Clin.Invest. 92. 1555-1558 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ware J et al: "Point mutation in a leucine-rich repeat of platelet glycoprotein Iba resulting in the Bernard-Soulier syndrome." J.Clin.Invest. 92. 1213-1220 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murata M et al: "Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant ghycoprotein Ibalpha fragment." J.Clin.Invest. 91. 2133-2137 (1993)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi